| 12383552 |
Diketopiperazine microparticles with defined specific surface areas |
Marshall L. Grant, Paul Menkin, John J. Freeman |
2025-08-12 |
|
| 11607410 |
Diketopiperazine microparticles with defined specific surface areas |
Marshall L. Grant, Paul Menkin, John J. Freeman |
2023-03-21 |
$14,048,000 |
| 11433135 |
High capacity diketopiperazine microparticles and methods |
Marshall L. Grant, Paul Menkin |
2022-09-06 |
$15,398,000 |
| 10772883 |
Diketopiperazine microparticles with defined specific surface areas |
Marshall L. Grant, Paul Menkin, John J. Freeman |
2020-09-15 |
$3,486,000 |
| 10603383 |
High capacity diketopiperazine microparticles and methods |
Marshall L. Grant, Paul Menkin |
2020-03-31 |
$1,526,000 |
| 10376587 |
High capacity diketopiperazine microparticles and methods |
Marshall L. Grant, Paul Menkin |
2019-08-13 |
$2,853,000 |
| 10258664 |
Methods and compositions for treating pain |
Andrea Leone-Bay, Richard A. Houghten, Joseph J. Guarneri |
2019-04-16 |
$8,322,000 |
| 10130709 |
High capacity diketopiperazine microparticles and methods |
Marshall L. Grant, Paul Menkin |
2018-11-20 |
$2,791,000 |
| 9630930 |
Diketopiperazine microparticles with defined specific surface areas |
Marshall L. Grant, Paul Menkin |
2017-04-25 |
$1,877,000 |
| 9610351 |
Methods and compositions for treating pain |
Andrea Leone-Bay, Richard A. Houghten, Joseph J. Guarneri |
2017-04-04 |
$2,938,000 |
| 9364436 |
High capacity diketopiperazine microparticles and methods |
Marshall L. Grant, Paul Menkin |
2016-06-14 |
$6,382,000 |
| 9233159 |
Methods and compositions for treating pain |
Andrea Leone-Bay, Richard A. Houghten, Joseph J. Guarneri |
2016-01-12 |
$7,229,000 |
| 8785396 |
Method and composition for treating migraines |
Andrea Leone-Bay, Joseph J. Guarneri, Dawn M. Carlson, Marshall L. Grant, Chad C. Smutney |
2014-07-22 |
$42,829,000 |
| 8778403 |
Diketopiperazine microparticles with defined specific surface areas |
Marshall L. Grant, Paul Menkin |
2014-07-15 |
$89,470,000 |
| 8734845 |
Diketopiperazine microparticles with defined specific surface areas |
Marshall L. Grant, Paul Menkin |
2014-05-27 |
$75,056,000 |
| 8642548 |
Val (8) GLP-1 composition and method for treating functional dyspepsia and/or irritable bowel syndrome |
Peter Richardson, Enda Kenny, Per Hellstrom, Marshall L. Grant, Scott Daniels +2 more |
2014-02-04 |
$31,002,000 |
| 8551528 |
Diketopiperazine microparticles with defined specific surface areas |
Marshall L. Grant, Paul Menkin |
2013-10-08 |
$24,897,000 |
| 6780880 |
FT-Raman spectroscopic measurement |
Robert R. Whittle, Frederick D. Sancilio |
2004-08-24 |
|
| 6706737 |
Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
Robert R. Whittle, Frederick D. Sancilio, Douglas John Jenkins |
2004-03-16 |
|
| 6673936 |
Process for purifying 6-methoxy omeprazole |
Linda B. Whittall, Robert R. Whittle |
2004-01-06 |
|
| 6667324 |
Dry blend pharmaceutical formulations |
Robert R. Whittle, Frederick D. Sancilio, Douglas John Jenkins, Linda B. Whittall |
2003-12-23 |
|
| 6667321 |
Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
Robert R. Whittle, Frederick D. Sancilio, Douglas John Jenkins, Linda B. Whittall |
2003-12-23 |
|
| 6667323 |
Dry-blend pharmaceutical formulations |
Robert R. Whittle, Frederick D. Sancilio, Douglas John Jenkins, Linda Whittall |
2003-12-23 |
|
| 6660864 |
Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone |
Robert R. Whittle |
2003-12-09 |
|
| 6657061 |
Polymorphic forms of 6-[4-1(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone |
Robert R. Whittle |
2003-12-02 |
|